MD20160019A2 - Compuşi noi de indazol şi procedeu de obţinere a acestora - Google Patents
Compuşi noi de indazol şi procedeu de obţinere a acestora Download PDFInfo
- Publication number
- MD20160019A2 MD20160019A2 MDA20160019A MD20160019A MD20160019A2 MD 20160019 A2 MD20160019 A2 MD 20160019A2 MD A20160019 A MDA20160019 A MD A20160019A MD 20160019 A MD20160019 A MD 20160019A MD 20160019 A2 MD20160019 A2 MD 20160019A2
- Authority
- MD
- Moldova
- Prior art keywords
- preparation
- indazole compounds
- novel indazole
- novel
- compounds
- Prior art date
Links
- 125000003453 indazolyl group Chemical class N1N=C(C2=C1C=CC=C2)* 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 208000002249 Diabetes Complications Diseases 0.000 abstract 1
- 206010012655 Diabetic complications Diseases 0.000 abstract 1
- 230000004706 cardiovascular dysfunction Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Prezenta invenţie se referă la compuşi noi de indazol cu formula generală Işi la analogi ai acestora, la utilizarea acestora pentru tratamentul diabetului zaharat, complicaţiilor diabetice, disfuncţiilor cardiovasculare sau al bolilor asociate, la compoziţii farmaceutice care îi conţin, precum şi la un procedeu de preparare a acestora.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2296DE2013 | 2013-07-31 | ||
| PCT/IN2014/000507 WO2015015519A1 (en) | 2013-07-31 | 2014-07-31 | Novel indazole compounds and a process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MD20160019A2 true MD20160019A2 (ro) | 2016-06-30 |
Family
ID=51795688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20160019A MD20160019A2 (ro) | 2013-07-31 | 2014-07-31 | Compuşi noi de indazol şi procedeu de obţinere a acestora |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9737510B2 (ro) |
| EP (1) | EP3027605B1 (ro) |
| JP (1) | JP6474808B2 (ro) |
| KR (1) | KR20160053916A (ro) |
| CN (1) | CN106103427B (ro) |
| AU (1) | AU2014297912A1 (ro) |
| BR (1) | BR112016002176A2 (ro) |
| CA (1) | CA2919953A1 (ro) |
| DK (1) | DK3027605T3 (ro) |
| EA (1) | EA201690240A1 (ro) |
| ES (1) | ES2656475T3 (ro) |
| MA (1) | MA38849B1 (ro) |
| MD (1) | MD20160019A2 (ro) |
| MX (1) | MX2016001331A (ro) |
| MY (1) | MY176807A (ro) |
| SG (1) | SG11201600744UA (ro) |
| WO (1) | WO2015015519A1 (ro) |
| ZA (1) | ZA201601177B (ro) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57501378A (ro) | 1980-09-05 | 1982-08-05 | ||
| PH27357A (en) | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
| AU8748798A (en) * | 1997-08-22 | 1999-03-16 | Kyowa Hakko Kogyo Co. Ltd. | 4-aminoquinazoline derivatives |
| ATE239013T1 (de) * | 1997-12-19 | 2003-05-15 | Lilly Co Eli | Hypoglykamische imidazoline derivate |
| JP2000154139A (ja) * | 1998-09-16 | 2000-06-06 | Kyowa Hakko Kogyo Co Ltd | 縮環ピラジン誘導体 |
| YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
| CA2440842A1 (en) | 2001-04-16 | 2002-10-24 | Eisai Co., Ltd. | Novel 1h-indazole compounds |
| EP1427707A1 (en) | 2001-09-19 | 2004-06-16 | Pharmacia Corporation | Substituted indazole compounds for the treatment of inflammation |
| US20040009976A1 (en) | 2002-04-30 | 2004-01-15 | Kumiko Takeuchi | Hypoglycemic imidazoline compounds |
| US6878735B2 (en) | 2002-05-31 | 2005-04-12 | Board Of Trustees Of Michigan State University | Multi-substituted imidazolines and method of use thereof |
| US20050090529A1 (en) * | 2003-07-31 | 2005-04-28 | Pfizer Inc | 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| US20060293370A1 (en) * | 2005-06-10 | 2006-12-28 | Saunders Jeffrey O | Sulfonamide compounds and uses thereof |
| CA2770320A1 (en) | 2009-08-10 | 2011-02-17 | Epitherix, Llc | Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
| US7947728B1 (en) | 2009-11-11 | 2011-05-24 | Hoffmann-La Roche Inc. | Indole and indazole analogs as glycogen synthase activators |
-
2014
- 2014-07-31 ES ES14789631.0T patent/ES2656475T3/es active Active
- 2014-07-31 BR BR112016002176A patent/BR112016002176A2/pt not_active Application Discontinuation
- 2014-07-31 CA CA2919953A patent/CA2919953A1/en not_active Abandoned
- 2014-07-31 MX MX2016001331A patent/MX2016001331A/es unknown
- 2014-07-31 MA MA38849A patent/MA38849B1/fr unknown
- 2014-07-31 MD MDA20160019A patent/MD20160019A2/ro not_active Application Discontinuation
- 2014-07-31 WO PCT/IN2014/000507 patent/WO2015015519A1/en not_active Ceased
- 2014-07-31 EP EP14789631.0A patent/EP3027605B1/en active Active
- 2014-07-31 MY MYPI2016700340A patent/MY176807A/en unknown
- 2014-07-31 EA EA201690240A patent/EA201690240A1/ru unknown
- 2014-07-31 JP JP2016530671A patent/JP6474808B2/ja not_active Expired - Fee Related
- 2014-07-31 AU AU2014297912A patent/AU2014297912A1/en not_active Abandoned
- 2014-07-31 KR KR1020167005168A patent/KR20160053916A/ko not_active Withdrawn
- 2014-07-31 SG SG11201600744UA patent/SG11201600744UA/en unknown
- 2014-07-31 DK DK14789631.0T patent/DK3027605T3/en active
- 2014-07-31 CN CN201480048261.9A patent/CN106103427B/zh not_active Expired - Fee Related
- 2014-07-31 US US14/908,805 patent/US9737510B2/en not_active Expired - Fee Related
-
2016
- 2016-02-22 ZA ZA2016/01177A patent/ZA201601177B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2919953A1 (en) | 2015-02-05 |
| US9737510B2 (en) | 2017-08-22 |
| EP3027605A1 (en) | 2016-06-08 |
| EP3027605B1 (en) | 2017-11-08 |
| CN106103427B (zh) | 2019-07-16 |
| KR20160053916A (ko) | 2016-05-13 |
| AU2014297912A1 (en) | 2016-02-25 |
| WO2015015519A1 (en) | 2015-02-05 |
| ZA201601177B (en) | 2017-11-29 |
| US20160185759A1 (en) | 2016-06-30 |
| SG11201600744UA (en) | 2016-02-26 |
| MA38849A1 (fr) | 2017-12-29 |
| CN106103427A (zh) | 2016-11-09 |
| JP6474808B2 (ja) | 2019-02-27 |
| BR112016002176A2 (pt) | 2017-08-01 |
| JP2016525570A (ja) | 2016-08-25 |
| MY176807A (en) | 2020-08-21 |
| MX2016001331A (es) | 2017-02-06 |
| EA201690240A1 (ru) | 2016-10-31 |
| DK3027605T3 (en) | 2018-01-22 |
| ES2656475T3 (es) | 2018-02-27 |
| MA38849B1 (fr) | 2018-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ608116A (en) | Triazine-oxadiazoles | |
| PH12016500094A1 (en) | Autotaxin inhibitors | |
| PH12015501385A1 (en) | Autotaxin inhibitors | |
| EA201491028A1 (ru) | Способ получения замещенных 5-фтор-1н-пиразолопиридинов | |
| MD20150091A2 (ro) | Compuşi antivirali | |
| MY170713A (en) | Treatment protocol of diabetes type 2 | |
| EA033544B1 (ru) | Производные пиридона в качестве ингибиторов киназы, реаранжированной во время трансфекции (ret) | |
| UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
| MX378732B (es) | Formas solidas novedosas | |
| PH12015500860A1 (en) | 2-phenyl -5- heterocyclyl -tetrahydro-2h- pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders | |
| IN2012DN02139A (ro) | ||
| UA116889C2 (uk) | Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc) | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| IN2014DN01629A (ro) | ||
| PH12018501709A1 (en) | Naphthridinedione derivatives | |
| PH12016500577B1 (en) | Piperazine derivatives and the use thereof as medicament | |
| GB201116017D0 (en) | Bi-aromatic and tri-aromatic compounds as nadph oxidase inhibitors | |
| MX2014003584A (es) | Derivados de metanosulfonamida sustituidos como ligandos de receptores vaniloides. | |
| EA201691465A1 (ru) | Средство для лечения сердечно-сосудистых заболеваний | |
| MY181682A (en) | Stabilised amorphous form of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| PH12016500788A1 (en) | Compounds for the treatment of diabetes and disease complications arising from same | |
| MD20160019A2 (ro) | Compuşi noi de indazol şi procedeu de obţinere a acestora | |
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| TN2013000441A1 (en) | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists | |
| EP2563785A4 (en) | Compounds as Agonists Against S1P1 Receptors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA9A | Abandonment or withdrawal of application (patent for invention) |